Gen-Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.21M Sell
12,624
-689
-5% -$161K 0.89% 19
2026
Q1
$3.25M Sell
13,313
-881
-6% -$205K 1.03% 18
2025
Q4
$2.94M Sell
14,194
-1,576
-10% -$312K 0.94% 19
2025
Q3
$2.92M Buy
15,770
+1,202
+8% +$206K 0.99% 16
2025
Q2
$2.23M Buy
14,568
+5
+0% +$769 0.86% 21
2025
Q1
$2.42M Buy
14,563
+956
+7% +$150K 1.01% 16
2024
Q4
$1.97M Buy
13,607
+468
+4% +$72.5K 0.85% 20
2024
Q3
$2.11M Sell
13,139
-96
-0.7% -$15.3K 0.92% 18
2024
Q2
$1.93M Buy
13,235
+1,217
+10% +$181K 0.93% 16
2024
Q1
$1.9M Buy
+12,018
New +$1.91M 0.94% 19

Other funds holding JNJ

Gen-Wealth Partners's JNJ Position: Q2 2026 in Review

Gen-Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 5.2% in Q2 2026, selling an estimated $161K and leaving 12,624 shares worth $3.21M. The position accounts for 0.89% of the portfolio, ranked #19.

Gen-Wealth Partners first reported a position in JNJ in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.25M in Q1 2026. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Gen-Wealth Partners held 12,624 shares of Johnson & Johnson worth $3.21M as of Q2 2026.
  • Gen-Wealth Partners sold 689 Johnson & Johnson shares in Q2 2026, an estimated $161K.
  • Johnson & Johnson made up 0.89% of Gen-Wealth Partners's portfolio in Q2 2026, its #19 holding.
  • Gen-Wealth Partners first reported a position in Johnson & Johnson in Q1 2024 and has held it in 10 quarters since.
  • Gen-Wealth Partners's Johnson & Johnson position peaked at $3.25M in Q1 2026.
  • 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.